Digitalis therapy for patients in clinical heart failure.
Rahimtoola
Shahbudin H
SH
Griffith Center, Division of Cardiovascular Medicine, Department of Medicine, Keck School of Medicine at USC, Los Angeles, Calif 90033, USA.
D000818:Animals; D001341:Autonomic Nervous System / Q000187:drug effects; D017704:Baroreflex / Q000187:drug effects; D002316:Cardiotonic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D002317:Cardiovascular Agents / Q000494:pharmacology / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004071:Digitalis Glycosides / Q000627:therapeutic use*; D004077:Digoxin / Q000627:therapeutic use; D004231:Diuresis / Q000187:drug effects; D004347:Drug Interactions; D006333:Heart Failure / Q000188:drug therapy*; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D008517:Phytotherapy; D017410:Practice Guidelines as Topic; D016032:Randomized Controlled Trials as Topic; D014655:Vascular Resistance / Q000187:drug effects; D014665:Vasodilator Agents / Q000627:therapeutic use
D002316:Cardiotonic Agents; D002317:Cardiovascular Agents; D004071:Digitalis Glycosides; D014665:Vasodilator Agents; D004077:Digoxin